Rationale for the use of N ‐acetylcysteine in both prevention and adjuvant therapy of COVID‐19-Reference-Cited by-全球学者库

Rationale for the use of N ‐acetylcysteine in both prevention and adjuvant therapy of COVID‐19

Published:2020-08-11 Issue:10 Volume:34 Page:13185-13193
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

De Flora Silvio¹,Balansky Roumen²,La Maestra Sebastiano¹

Affiliation:

1. Department of Health Sciences University of Genoa Genoa Italy

2. National Centre of Oncology Sofia Bulgaria

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202001807

Reference72 articles.

1. COVID‐19: immunopathology and its implications for therapy;Cao X;Nature Rev Immunol,2020

2. Molecular immune pathogenesis and diagnosis of COVID-19

3. A current review of COVID-19 for the cardiovascular specialist

4. Istituto Superiore di Sanità. Epicentro. Characteristics of SARS‐CoV‐2 patients dying in Italy. Report based on available data on May 28th 2020.https://www.epicentro.iss.it/en/coronavirus/sars‐cov‐2‐analysis‐of‐death

5. Sexual dimorphism in glutathione metabolism and glutathione‐dependent responses;Wang L;Redox Biol,2019

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS);Respiratory Research;2024-01-13

2. Identifying the Interaction Between Tuberculosis and SARS-CoV-2 Infections via Bioinformatics Analysis and Machine Learning;Biochemical Genetics;2023-11-22

3. Evaluation of the efficacy and safety of oral N‐acetylcysteine in patients with COVID‐19 receiving the routine antiviral and hydroxychloroquine protocol: A randomized controlled clinical trial;Immunity, Inflammation and Disease;2023-11

4. Hydrogen sulfide: From a toxic gas to a potential therapy for COVID-19 and inflammatory disorders;Nitric Oxide;2023-11

5. Molecular studies of phages-Klebsiella pneumoniae in mucoid environment: innovative use of mucolytic agents prior to the administration of lytic phages;Frontiers in Microbiology;2023-10-11